Valuation: Cencora, Inc.

Market Cap 61.8B 55.39B 51.56B 46.79B 88.26B 5,918B 88.84B 621B 243B 3,048B 232B 227B 9,798B P/E 2026 *
17.7x
P/E 2027 * 18.8x
Enterprise Value 69.49B 62.28B 57.97B 52.61B 99.24B 6,654B 99.89B 698B 273B 3,427B 261B 255B 11,017B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.2x
Free-Float
61.21%
Yield 2026 *
0.73%
Yield 2027 * 0.75%
1 day+0.37%
1 week+3.22%
Current month+8.26%
1 month+1.09%
3 months+7.12%
6 months+1.32%
Current year-3.76%
1 week 314.9
Extreme 314.9
327.96
1 month 295.01
Extreme 295.01
327.96
Current year 244.82
Extreme 244.82
376.92
1 year 244.82
Extreme 244.82
377.54
3 years 182.75
Extreme 182.75
377.54
5 years 113.68
Extreme 113.68
377.54
10 years 68.38
Extreme 68.38
377.54
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

Director

275 0.0001%
10/1/26 Sell

Controller/Auditor

-986 0.0005%
10/1/26 Other

Director

197 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+3.22%+2.22%+73.30% 61.8B
+2.23%+1.72%-23.20%+12.89% 172B
+3.90%+4.50%-3.69%+28.95% 113B
+1.90%-0.92%-22.49%+11.33% 106B
+0.27%+1.56%-46.32%-11.83% 75.31B
+0.12%+2.27%+15.06%+60.71% 52.93B
+2.80%+4.55%+1.25%-26.52% 50.05B
+1.15%-0.59%-14.97%+22.33% 40.81B
-1.38%-0.11% - - 31.81B
+2.15%-1.13%+31.94%+13.82% 31.74B
Average +0.89%+2.04%-6.69%+20.55% 73.64B
Weighted average by Cap. +1.04%+2.17%-12.63%+19.27%

Financials

2026 *2027 *
Net sales 337B 302B 281B 255B 481B 32,274B 484B 3,385B 1,324B 16,621B 1,266B 1,238B 53,434B 352B 315B 294B 266B 503B 33,700B 506B 3,535B 1,383B 17,355B 1,322B 1,292B 55,794B
Net income 3.58B 3.21B 2.99B 2.71B 5.11B 343B 5.15B 35.96B 14.07B 177B 13.45B 13.15B 568B 3.28B 2.94B 2.73B 2.48B 4.68B 314B 4.71B 32.91B 12.87B 162B 12.3B 12.03B 519B
Net Debt 7.69B 6.89B 6.42B 5.82B 10.98B 736B 11.05B 77.25B 30.22B 379B 28.88B 28.24B 1,219B 9.44B 8.46B 7.87B 7.14B 13.48B 904B 13.56B 94.79B 37.08B 465B 35.44B 34.66B 1,496B
Projected Income Statement - Annual - Cencora, Inc.
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change Volume
26-10-12 US$325.06 +0.37% 959,153
26-10-09 US$323.85 +0.78% 781,945
26-10-08 US$321.35 +1.29% 897,578
26-10-07 US$317.25 +0.28% 1,060,756
26-10-06 US$316.37 +0.46% 817,905
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Cencora, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
323.85USD
Average target price
369.92USD
Spread / Average Target
+14.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cencora, Inc.